Aura Biosciences, Inc.
AURA
Rank in Stocks
#9758
Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a... Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.
Share Price
$7.66
Last synced: 2026-11-09
Market Cap
$794.38M
Change (1 day)
16.77%
Change (1 year)
35.34%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Aura Biosciences, Inc. (AURA)
Category
Healthcare
EPS for Aura Biosciences, Inc. (AURA)
EPS as of June 2026 TTM: $-1.78
According to Aura Biosciences, Inc.'s latest financial reports, its current EPS (TTM) is $-1.78. At the end of 2025 the company had an EPS of $-1.76, a decrease compared to its 2024 EPS of $-1.75.
EPS history for Aura Biosciences, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.78 | 1.14% |
| 2025 | $-1.76 | 0.57% |
| 2024 | $-1.75 | -9.33% |
| 2023 | $-1.93 | -1.53% |
| 2022 | $-1.96 | 24.05% |
| 2021 | $-1.58 | 53.40% |
| 2020 | $-1.03 | 12,309.64% |
| 2019 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -979.78% |
US
|
|
| $-7.07 | 297.19% |
US
|
|
| $-5.29 | 197.19% |
AU
|
|
| $12.88 | -823.60% |
BE
|
|
| $21.56 | -1,311.24% |
NL
|
Questions about Aura Biosciences, Inc.'s earnings per share (EPS)
What is Aura Biosciences, Inc.'s earnings per share (EPS)?
Aura Biosciences, Inc.'s earnings per share (EPS) over the last twelve months is $-1.78, as of Jun 2026.
What was Aura Biosciences, Inc.'s earnings per share (EPS) in 2025?
In 2025, Aura Biosciences, Inc.'s earnings per share (EPS) was $-1.76, compared with $-1.75 in 2024.
How has Aura Biosciences, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Aura Biosciences, Inc.'s earnings per share (EPS) was highest in 2020 ($-1.03) and lowest in 2022 ($-1.96).
How does Aura Biosciences, Inc.'s earnings per share (EPS) compare with similar companies?
Aura Biosciences, Inc.'s earnings per share (EPS) ($-1.78) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.